These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 25086876

  • 21. Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats.
    Ehtesham M, Kabos P, Gutierrez MA, Samoto K, Black KL, Yu JS.
    J Immunother; 2003; 26(2):107-16. PubMed ID: 12616102
    [Abstract] [Full Text] [Related]

  • 22. Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas.
    Mariani CL, Rajon D, Bova FJ, Streit WJ.
    J Neurooncol; 2007 Dec; 85(3):231-40. PubMed ID: 17568998
    [Abstract] [Full Text] [Related]

  • 23. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW, Demaria S, Lukyanov Y, Shao Y, Schnee T, Kawashima N, Lan L, Dewyngaert JK, Zagzag D, McBride WH, Formenti SC.
    Clin Cancer Res; 2006 Aug 01; 12(15):4730-7. PubMed ID: 16899624
    [Abstract] [Full Text] [Related]

  • 24. Impaired capacity for upregulation of MHC class II in tumor-associated microglia.
    Schartner JM, Hagar AR, Van Handel M, Zhang L, Nadkarni N, Badie B.
    Glia; 2005 Sep 01; 51(4):279-85. PubMed ID: 15818597
    [Abstract] [Full Text] [Related]

  • 25. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
    Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, Phi JH, Park IH, Black PM, Carroll RS, Lee J, Kim SK.
    Clin Cancer Res; 2009 Aug 01; 15(15):4925-34. PubMed ID: 19638465
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
    Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P.
    Scand J Immunol; 2007 Mar 01; 65(3):289-97. PubMed ID: 17309784
    [Abstract] [Full Text] [Related]

  • 27. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
    Siesjö P, Visse E, Sjögren HO.
    J Immunother Emphasis Tumor Immunol; 1996 Sep 01; 19(5):334-45. PubMed ID: 8941873
    [Abstract] [Full Text] [Related]

  • 28. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X, Hu J, Belladonna ML, Black KL, Yu JS.
    Cancer Res; 2006 Mar 01; 66(5):2630-8. PubMed ID: 16510582
    [Abstract] [Full Text] [Related]

  • 29. [A new experimental approach to the specific adoptive immunotherapy for malignant gliomas].
    Yamasaki T.
    Nihon Geka Hokan; 1983 Nov 01; 52(6):783-801. PubMed ID: 6331809
    [No Abstract] [Full Text] [Related]

  • 30. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH, Park KY, Kim SM, Jeong CH, Woo JS, Hou Y, Jeun SS.
    Biochem Biophys Res Commun; 2012 May 11; 421(3):585-90. PubMed ID: 22525671
    [Abstract] [Full Text] [Related]

  • 31. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
    Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA, Cui X, Cummings TJ, Bigner DD, Gilboa E, Sampson JH.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4294-305. PubMed ID: 16857805
    [Abstract] [Full Text] [Related]

  • 32. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
    Ohshima M, Yamahara K, Ishikane S, Harada K, Tsuda H, Otani K, Taguchi A, Miyazato M, Katsuragi S, Yoshimatsu J, Kodama M, Kangawa K, Ikeda T.
    J Mol Cell Cardiol; 2012 Sep 15; 53(3):420-8. PubMed ID: 22796574
    [Abstract] [Full Text] [Related]

  • 33. Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.
    Xu G, Guo Y, Seng Z, Cui G, Qu J.
    Oncol Rep; 2015 Oct 15; 34(4):1915-22. PubMed ID: 26252165
    [Abstract] [Full Text] [Related]

  • 34. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M.
    Int J Oncol; 2003 Aug 15; 23(2):483-8. PubMed ID: 12851699
    [Abstract] [Full Text] [Related]

  • 35. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
    Parker Kerrigan BC, Shimizu Y, Andreeff M, Lang FF.
    Cytotherapy; 2017 Apr 15; 19(4):445-457. PubMed ID: 28233640
    [Abstract] [Full Text] [Related]

  • 36. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 37. Immunotherapy of malignant gliomas.
    Maleci A.
    J Neurosurg Sci; 1989 May 01; 33(1):77-82. PubMed ID: 2674361
    [Abstract] [Full Text] [Related]

  • 38. Recent advances of dendritic cells (DCs)-based immunotherapy for malignant gliomas.
    Cho DY, Lin SZ, Yang WK, Hsu DM, Lee HC, Lee WY, Liu SP.
    Cell Transplant; 2009 May 01; 18(9):977-83. PubMed ID: 19523342
    [Abstract] [Full Text] [Related]

  • 39. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.
    Schmitz M, Temme A, Senner V, Ebner R, Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert HK, Fussel M, Bachmann M, Rieber EP, Weigle B.
    Br J Cancer; 2007 Apr 23; 96(8):1293-301. PubMed ID: 17375044
    [Abstract] [Full Text] [Related]

  • 40. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ, Kim HS, Lee HG, Kim GJ, Jeon HG, Shin HS, Chang SK, Hur GH, Chong SY, Oh D, Chung HM.
    Acta Haematol; 2013 Apr 23; 129(4):197-206. PubMed ID: 23257958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.